Tyro Capital Management’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding TRVI
Tyro Capital Management's TRVI Position: Q3 2026 in Review
Tyro Capital Management opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 291,890 shares worth $4.18M. The stake represents 0.74% of the portfolio and ranks #24 among its holdings.
223 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.
- Tyro Capital Management held 291,890 shares of Trevi Therapeutics worth $4.18M as of Q3 2026.
- Trevi Therapeutics was a new Tyro Capital Management position in Q3 2026.
- Trevi Therapeutics made up 0.74% of Tyro Capital Management's portfolio in Q3 2026, its #24 holding.
- 223 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.
Based on Tyro Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.